A Phase 2, Open-Label Study of the Safety and Efficacy of INCB040093 and INCB040093 Combined With INCB039110 in Subjects With Relapsed or Refractory Hodgkin Lymphoma
|Effective start/end date||8/1/15 → 8/30/20|
- INCYTE CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.